Related Articles
Immunolocalization of the components of the plasminogen activating system in breast carcinoma tissue
Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: An EORTC Receptor and Biomarker Group collaboration
The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion
Tissue urokinase-type plasminogen activator receptor levels in breast cancer.
Decreased expression of the plasminogen activator inhibitor type 1 is involved in degradation of extracellular matrix surrounding cervical cancer stem cells